Synergy Biologics, is proud to announce the launch of its first licensed vitamin D products with the release to the UK prescription medicines market of the Colextra-D3 (Colecalciferol) range.
There are currently four Colextra-D3 variants in the initial launch:
Colextra-D3 800 IU (Colecalciferol) Capsules, Soft – pack size 30,
Colextra-D3 20,000 IU (Colecalciferol) Capsules, Soft – pack size 10,
Colextra-D3 20,000 IU (Colecalciferol) Capsules, Soft – pack size 30,
Colextra-D3 25,000 IU (Colecalciferol) Tablets – pack size 12,
The Colextra-D3 (Colecalciferol) range provides a comprehensive, flexible, and cost-effective licensed choice for the treatment and prevention of vitamin D deficiency and osteoporosis.
The Colextra-D3 products are prescription-only-products and are available to order via leading mainline pharmaceutical wholesalers including AAH Pharmaceuticals and Phoenix Healthcare.
Synergy Biologics continues to be focused on bringing innovative, value added, products to the UK healthcare markets, providing products that improve the lives of patients in a cost-effective and ethical manner.
Comments